Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,236 results that match your search.22,236 results
  • Life science companies face unique patent issues, for example concerning relief, exemptions and supplementary protection. Bert Oosting, Andreas von Falck, Stanislas Roux-Vaillard, Stephen Bennett and Daniel Brook examine how these questions will be addressed in the proposed UPC
  • If there is an opposition to an application for trade mark registration, the applicant is entitled to commence the action of withdrawal of that opposition.
  • Recently, in Couture v Playdom, Inc, the US Court of Appeals for the Federal Circuit addressed for the first time whether a trade mark applicant's offering of a service, without actually providing such services, is sufficient to constitute to use of a mark in commerce.
  • Pfizer has recently successfully resisted the Australian Competition Commission's attempts to shut down its patent evergreening activities in trying to leverage its atorvastatin (Lipitor) patent past its end of term.
  • The licensing of names and images from fictional works, including the names of cartoon characters and film titles, is growing exponentially in the PRC and in relation to an ever-widening range of consumer goods. While media companies, including Hollywood studios, have the most to gain from this sector, their business partners stand to benefit greatly also, including overseas companies taking master licences, local Chinese licensees and companies managing the licensing activity of others on their behalf.
  • A constitutional action was filed by an innovator pharmaceutical company before a district court against COFEPRIS, contesting the granting of a marketing authorisation for a generic medicine. This action was essentially based on: (1) the lack of opportunity for the title holder to be heard during the prosecution of the marketing authorisation application; (2) the need to have knowledge about the contents of the generic company's application and (3) the unconstitutionality of the Linkage Regulation as it does not allow a patent owner to have knowledge of a potential violation of the patent linkage system in the marketing authorisations of generics.
  • Forty three tukutuku panels (a distinctive art form of the Māori people of New Zealand), woven by artists from around the country, now hang in the United Nations headquarters in New York.
  • On February 6 2015, the Food and Drug Administration (FDA) issued Memorandum Circular No 2015-003 reiterating the FDA's disallowance of the phrase "No Approved Therapeutic Claim" in any form of advertisement, promotion, sponsorship activities or materials concerning food/dietary supplements, as embodied in FDA Administrative Order No 2010-008.
  • Cartier International appealed against the decision of the examiner rejecting protection in Russia for an international trade mark number 1111659 in respect of goods in classes 14 and services in class 35 with convention priority of December 22 2011.
  • If a trade mark owner finds out that his mark has been registered as a .tw country code top-level domain (ccTLD) by another party, he may file a complaint with an approved dispute resolution service provider based on Article 5.1 of the Domain Name Dispute Resolution Policy promulgated by the Taiwan Network Information Center (TWNIC).